The MPN Research Foundation: Various Opportunities

The 2022 Thrive Initiative is a unique research funding opportunity focused on supporting and expanding research in MPNs to catalyze significant discoveries leading to a better understanding and new treatment options for patients with myeloproliferative neoplasms (MPNs), myelofibrosis (MF), polycythemia vera (PV) and essential thrombocythemia (ET). 

Funding: up to $200,000 for 2 years. Overhead 8%

https://www.mpnresearchfoundation.org/apply-for-funding/?utm_source=Constant+Contact&utm_medium=Email&utm_campaign=2022-06+RFA+Announcement-02